IZ Express

Issue 1749: March 27, 2024

Top Stories
Immunize.org Website and Clinical Resources
Featured Resources
Upcoming Events
Top Stories

Download the updated suite of Immunize.org vaccine storage and excursion response materials, including temperature logs and emergency response worksheets

Immunize.org updated its entire suite of vaccine storage and response materials to align with the current CDC guidance for temperature monitoring in line with its Vaccine Storage and Handling Toolkit. They now accommodate two options for how to monitor temperatures in standard freezers or refrigerators, depending upon whether temperature monitoring is done with CDC-preferred continuous digital data loggers that display minimum and maximum temperatures (min/max), or other acceptable temperature monitoring devices without min/max displays. QR codes linking to online versions of the documents were added. Facilities using our temperature logs and vaccine storage emergency response worksheets should download these updated logs.

In addition to temperature logs, Immunize.org updated two resources designed to help you manage vaccine temperature excursions.

  • Vaccine Storage Emergency Response Worksheet: this worksheet helps healthcare professionals document inventory and evaluate vaccine usability in the aftermath of power failures and temperature excursions. The worksheet now has a column to document the funding source (e.g., VFC, private) of each vaccine lot affected.
  • Vaccine Storage Troubleshooting Record: this fillable form can document the conditions and staff response to any unacceptable vaccine storage event, such as exposures to temperatures that are outside the manufacturers' recommended storage ranges

Below are the links to Immunize.org’s four temperature logs to help track proper vaccine storage and handling. Temperature logs are available for refrigerators and standard (not ultra-cold) freezers in Celsius or Fahrenheit formats.

Related Links

Immunize.org “Ask the Experts: COVID-19” web section updated with new recommendations for adults age 65 and older

Immunize.org reviewed and updated its popular Ask the Experts: COVID-19 web page. Clinical questions and answers now reflect updates made by ACIP in February 2024, recommending administration of an additional dose of any 2023–2024 Formula COVID-19 vaccine for people age 65 and older at least 4 months after the most recent dose of 2023–2024 Formula COVID-19 vaccine. Updates were also made to VAERS reporting guidance, distinguishing between guidance for fully licensed products and products used under emergency use authorization.

Immunize.org’s Ask the Experts main page leads you to 30 web pages on various topics with more than 1,300 common or challenging questions and answers about vaccines and their administration. Immunize.org’s team of experts includes Kelly L. Moore, MD, MPH (team lead), Carolyn B. Bridges, MD, FACP, and Iyabode Beysolow, MD, MPH.

Related Links

Immunize.org updates “Meningococcal B Vaccine Recommendations by Age and Risk Factor” to include optional use of pentavalent MenABCWY

Immunize.org updated its one-page quick reference chart for healthcare providers, Meningococcal B Vaccine Recommendations by Age and Risk Factor. The chart includes the option to use pentavalent MenABCWY (Penbraya, Pfizer) when both MenACWY and Trumenba brand MenB vaccines are indicated at the same visit.

Related Links

Immunize.org updates “DTaP, Tdap, and Td Catch-Up Vaccination Recommendations by Prior Vaccine History and Age” to include CDC guidance for Td use in certain children younger than age 7 years

Immunize.org recently revised its 1-page guidance for healthcare professionals titled DTaP, Tdap, and Td Catch-Up Vaccination Recommendations by Prior Vaccine History and Age. References to DT vaccine, which is no longer available, were deleted. DT had been used in children younger than age 7 years who had a history of developing encephalopathy within 7 days after DTaP vaccination, not due to another cause. In this rare circumstance, CDC now recommends off-label use of Td vaccine, licensed for age 7 years or older, in these children who are younger than age 7, on the same schedule as would be followed to complete DTaP series.

Related Links

Immunize.org updates “Key Vaccination Resources for Healthcare Professionals” training guide organized by experience level

Immunize.org recently updated its Key Vaccination Resources for Healthcare Professionals 5-page training guide for providers. Minor edits were made to add new resources and update URLs. Review this resource to ensure you and your team are not missing out on vaccination training and resources to support your work.

Related Link

Influenza-like illness activity remains elevated nationally, shows signs of decline; continue to offer flu vaccine

CDC’s Weekly U.S. Influenza Surveillance Report, FluView, provides a valuable picture of laboratory-confirmed influenza and influenza-like illness activity state by state.

Influenza Surveillance
For week 11, ending March 16, CDC’s Weekly U.S. Influenza Surveillance Report, FluView shows that seasonal influenza activity remains elevated nationally but is showing signs of decline. Activity is decreasing or stable in nine HHS regions and increasing slightly in the Pacific Northwest. Nationwide, 3.4% of patient visits reported through the Outpatient Influenza-Like Illness Surveillance Network (ILINet) were due to respiratory illness that included fever plus a cough or sore throat (i.e., ILI). The national baseline is 2.5%. Five pediatric influenza-associated deaths were reported this week, bringing the total to 121 children who died of influenza thus far during the 2023–2024 season.

Visit the CDC Respiratory Virus Hospitalization Surveillance Network (RESP-NET) for weekly reports of hospitalizations across the United States due to three vaccine-preventable seasonal respiratory viruses: COVID-19, influenza, and RSV.

Influenza Vaccination Dashboard
CDC's Weekly Flu Vaccination Dashboard shows that healthcare claims for adults in the 2023–2024 season were lower by 6.33 million doses compared with the same time last year. These data, through March 2, are based on doses administered in community pharmacies and physicians’ medical offices.

CDC recommends everyone age 6 months and older get annual influenza vaccination. Influenza and other vaccines (e.g., COVID-19 and pneumococcal vaccines) may be given at the same visit, if indicated. Infants age 6 months and older may receive influenza and COVID-19 vaccines at the same visit.

Locate influenza and COVID-19 vaccines in your area by entering your zip code in the VaccineFinder on Vaccines.gov or Vacunas.gov. To be listed as a provider by VaccineFinder, see the information on this website.

Related Links

“How Do We Avoid the Problem of Lost HepB Records for Adult Patients We Vaccinate Now?” Watch the 2-minute answer, part of the Ask the Experts Video Series on YouTube.

This week, our featured episode from the Ask the Experts Video Series is How Do We Avoid the Problem of Lost HepB Records for Adult Patients We Vaccinate Now? The video briefly describes the importance of adult vaccination documentation, especially because adults may receive vaccine doses from different providers and the HepB vaccine series is usually only needed once in a lifetime.

The 2-minute video is available on our YouTube channel, along with our full collection of quick video answers to popular Ask the Experts questions.

Like, follow, and share Immunize.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise:

Journalists interview Immunize.org experts

Journalists seek out Immunize.org experts to help explain vaccines to the public and policy makers. We help the media understand and communicate the complex work vaccinators do. Here is a selection of our recent citations.

Vaccines in the news

These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.

Immunize.org Website and Clinical Resources

Recap: Immunize.org updates "Pneumococcus: Questions and Answers"

Immunize.org updated our patient resource Pneumococcus: Questions and Answers. Answers incorporate recommendations for PCV20 vaccine for children and teens. Information about the CDC PneumoRecs Vax Advisor mobile app was added. This easy-to-use app helps healthcare professionals determine the pneumococcal vaccine doses needed for their patients, in accordance with current ACIP recommendations for children and adults.

Related Links

Recap: Immunize.org updates “Ask the Experts: HPV” web section

Immunize.org reviewed and updated its popular Ask the Experts: HPV web page, updating disease epidemiology and resource references, as needed.

Immunize.org’s Ask the Experts main page leads you to 30 web pages on various topics with more than 1,300 common or challenging questions and answers about vaccines and their administration. Immunize.org’s team of experts includes Kelly L. Moore, MD, MPH (team lead), Carolyn B. Bridges, MD, FACP, and Iyabode Beysolow, MD, MPH.

Related Links

Spotlight on the website: Try out the new Immunize.org website on your smartphone!

Our new website is designed to adapt seamlessly to the smaller screens of tablets and smartphones with configurations that make it simple to read and use. Navigation is responsive and features easy-access links for finger scrolling.

When you open the site, start your search using the “hamburger” menu icon or search feature at the top right of the screen on the home page. After clicking on the hamburger, you have instant access to content categories. Below are screenshots of the home page and first-level content categories. Try out the new look and feel on your smartphone today!

Featured Resources

Place your order! Sturdy, laminated versions of the 2024 U.S. immunization schedules from Immunize.org now shipping.

Laminated versions of the 2024 U.S. child and adolescent immunization schedule and the 2024 U.S. adult immunization schedule are available and shipping now. We do anticipate selling out, so if you need some, do not delay!

While the schedules are available online from CDC at no cost, Immunize.org’s printed, laminated booklets are ideal for use in any busy healthcare setting where vaccinations are given.

  • Durable: their tough coating can be wiped down, and they’re durable enough to stand up to a year's worth of use
  • Format: each schedule is produced in a 16-page, 8.5” X 11” booklet format; with color coding for easy reading, our laminated schedules replicate the original CDC formatting, including all tables and notes
  • Easy access to CDC updates: CDC added an online addendum page to the schedule, where new recommendations from ACIP made during 2024 can be posted. The laminated schedule addendum pages include custom QR codes you can scan to view or print the current CDC addendum from CDC's website, as needed.
  • Adult schedule bonus content: the adult schedule includes a bonus page with Immunize.org’s popular 1-page handout summarizing the dose, route, and needle size recommendations for all vaccines and recipients


1 copy: $10.00
2–4 copies: $9.50 each
5–19 copies: $8.50 each
20–99 copies: $7.50 each
100–499 copies: $6.00 each
500–999 copies: $5.00 each
1,000–1,999 copies: $4.00 each
2,000+ copies: $3.25 each

Visit the Shop Immunize.org: Laminated Schedules web page to view images of all the pages, to download the order form, and to order today!

For additional information, call 651-647-9009 or email admininfo@immunize.org.

Related Links

Updated 65+ Flu Defense website offers resources for healthcare professionals serving older adults

Confident recommendations for influenza vaccine from healthcare providers are powerfully persuasive. To assist you in maximizing protection for your patients, Immunize.org, in collaboration with CSL Seqirus, updated the 65+ Flu Defense website.

Older adults are at increased risk of severe influenza and COVID-19 illness, including hospitalization and death, especially if they are not up to date on these vaccinations. An updated fact sheet on the website, The Importance of Preventing Influenza and COVID-19, offers responses to help guide discussions with patients on the importance of preventing influenza and COVID-19.

This helpful site includes information, tools, and tips for communicating with adults age 65 and older about the scope and severity of influenza. Resources include:

Check out the updated 65+ Flu Defense website at www.influenza-defense.org to assist your ongoing efforts in protecting this vulnerable population.

Upcoming Events

On-Demand: NFID hosts webinar titled “Addressing Gaps in Vaccine Access and Coverage” on March 27 at 1:00 p.m. (ET); CME credit available

NFID will host a webinar titled Addressing Gaps in Vaccine Access and Coverage, 1:00–2:00 p.m. (ET) on March 27. NFID Medical Director Robert (Bob) H. Hopkins, Jr., MD, will moderate the discussion with Rachel H. Banks, MPIA, NAFSA: Association of International Educators; Lisa G. Foster, Adult Vaccine Access Coalition; and NFID President-Elect Jeffery A. Goad, PharmD, MPH. Panelists will discuss the current policy environment; factors limiting access to critical travel, outbreak, and occupational vaccines; and potential solutions to ensure vaccine access for patients with commercial insurance.

CME credit is available. There is no fee to participate in this activity, but preregistration is required.

Register for the webinar.

NFID hosts monthly webinars to increase awareness of the importance of infectious disease prevention and treatment. CME, CNE, and CPE credit are available for select recordings. View all archived NFID webinars.

Virtual: Clinical Education Alliance hosts two free webinars addressing shingles and RSV vaccinations for adults on April 16 and 17; CME credit available

Two live symposia on adult vaccination are being broadcast by Clinical Education Alliance, a healthcare professional education company. Free CME credit will be provided by Clinical Care Options, LLC. These sessions are sponsored by an educational grant from GSK.

For more upcoming events, visit our Calendar of Events.

About IZ Express

IZ Express is supported in part by Grant No. 1NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.

IZ Express Disclaimer
ISSN 2771-8085

Editorial Information

  • Editor-in-Chief
    Kelly L. Moore, MD, MPH
  • Managing Editor
    John D. Grabenstein, RPh, PhD
  • Associate Editor
    Sharon G. Humiston, MD, MPH
  • Writer/Publication Coordinator
    Taryn Chapman, MS
    Courtnay Londo, MA
  • Style and Copy Editor
    Marian Deegan, JD
  • Web Edition Managers
    Arkady Shakhnovich
    Jermaine Royes
  • Contributing Writer
    Laurel H. Wood, MPA
  • Technical Reviewer
    Kayla Ohlde

This page was updated on .